Literature DB >> 33357410

Allosteric HIV Integrase Inhibitors Promote Formation of Inactive Branched Polymers via Homomeric Carboxy-Terminal Domain Interactions.

Kushol Gupta1, Audrey Allen2, Carolina Giraldo1, Grant Eilers2, Robert Sharp1, Young Hwang2, Hemma Murali1, Katrina Cruz3, Paul Janmey3, Frederic Bushman4, Gregory D Van Duyne5.   

Abstract

The major effect of allosteric HIV integrase (IN) inhibitors (ALLINIs) is observed during virion maturation, where ALLINI treatment interrupts IN-RNA interactions via drug-induced IN aggregation, leading to the formation of aberrant virions. To understand the structural changes that accompany drug-induced aggregation, we determined the soft matter properties of ALLINI-induced IN aggregates. Using small-angle neutron scattering, SEM, and rheology, we have discovered that the higher-order aggregates induced by ALLINIs have the characteristics of weak three-dimensional gels with a fractal-like character. Their formation is inhibited by the host factor LEDGF/p75, as well as ex vivo resistance substitutions. Mutagenesis and biophysical analyses reveal that homomeric carboxy-terminal domain interactions are required to achieve the branched-polymer nature of the ALLINI-induced aggregates. These studies provide key insight into the mechanisms of ALLINI action and resistance in the context of the crowded virion environment where ALLINIs exert their effect.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ALLINI; HIV; analytical ultracentrifugation; host factors; oligomerization; polymer network; retroviral integration; rheology; small-angle X-ray scattering; small-angle neutron scattering

Year:  2020        PMID: 33357410      PMCID: PMC7935764          DOI: 10.1016/j.str.2020.12.001

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  84 in total

1.  Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.

Authors:  Frauke Christ; Arnout Voet; Arnaud Marchand; Stefan Nicolet; Belete A Desimmie; Damien Marchand; Dorothée Bardiot; Nam Joo Van der Veken; Barbara Van Remoortel; Sergei V Strelkov; Marc De Maeyer; Patrick Chaltin; Zeger Debyser
Journal:  Nat Chem Biol       Date:  2010-05-16       Impact factor: 15.040

Review 2.  HIV-1 antiretroviral drug therapy.

Authors:  Eric J Arts; Daria J Hazuda
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  Acetylation of HIV-1 integrase by p300 regulates viral integration.

Authors:  Anna Cereseto; Lara Manganaro; Maria Ines Gutierrez; Mariaelena Terreni; Antonio Fittipaldi; Marina Lusic; Alessandro Marcello; Mauro Giacca
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

4.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.

Authors:  F Dyda; A B Hickman; T M Jenkins; A Engelman; R Craigie; D R Davies
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

5.  Oligomeric states of the HIV-1 integrase as measured by time-resolved fluorescence anisotropy.

Authors:  E Deprez; P Tauc; H Leh; J F Mouscadet; C Auclair; J C Brochon
Journal:  Biochemistry       Date:  2000-08-08       Impact factor: 3.162

6.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

7.  Structural properties of HIV integrase. Lens epithelium-derived growth factor oligomers.

Authors:  Kushol Gupta; Tracy Diamond; Young Hwang; Frederic Bushman; Gregory D Van Duyne
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

Review 8.  The structural biology of HIV-1: mechanistic and therapeutic insights.

Authors:  Alan Engelman; Peter Cherepanov
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

9.  The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.

Authors:  Lei Feng; Venkatasubramanian Dharmarajan; Erik Serrao; Ashley Hoyte; Ross C Larue; Alison Slaughter; Amit Sharma; Matthew R Plumb; Jacques J Kessl; James R Fuchs; Frederic D Bushman; Alan N Engelman; Patrick R Griffin; Mamuka Kvaratskhelia
Journal:  ACS Chem Biol       Date:  2016-03-02       Impact factor: 5.100

10.  A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75.

Authors:  Stephen Hare; Ming-Chieh Shun; Saumya Shree Gupta; Eugene Valkov; Alan Engelman; Peter Cherepanov
Journal:  PLoS Pathog       Date:  2009-01-09       Impact factor: 6.823

View more
  4 in total

1.  Retroviral integrase: Structure, mechanism, and inhibition.

Authors:  Dario Oliveira Passos; Min Li; Robert Craigie; Dmitry Lyumkis
Journal:  Enzymes       Date:  2021-08-23

Review 2.  Multimodal Functionalities of HIV-1 Integrase.

Authors:  Alan N Engelman; Mamuka Kvaratskhelia
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

Review 3.  Structure and function of retroviral integrase.

Authors:  Goedele N Maertens; Alan N Engelman; Peter Cherepanov
Journal:  Nat Rev Microbiol       Date:  2021-07-09       Impact factor: 60.633

4.  Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors.

Authors:  Parmit Kumar Singh; Wen Li; Gregory J Bedwell; Hind J Fadel; Eric M Poeschla; Alan N Engelman
Journal:  Viruses       Date:  2022-08-26       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.